Related Experiment Video
Updated: Mar 8, 2026

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Maternal, Obstetric, and Perinatal Outcomes in Late Preterm and Term Births with Gestational Diabetes versus
Katherine L Grantz1, Jessica L Gleason1, Edwina Yeung1
1Epidemiology Branch, Division of Population Health Research, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, United States.
Objective:
The objective of this study was to evaluate obstetric, maternal, and perinatal outcomes by delivery week for pregnancies with gestational diabetes mellitus (GDM) and without diabetes.
Study Design:
We conducted a secondary analysis of electronic medical record data from 9,696 (5.3%) GDM pregnancies and 173,323 pregnancies without any diabetes delivered at 34 to 40 weeks. Composite and individual outcomes included maternal (e.g., death, hypertensive disorders, hemorrhage); primary neonatal morbidity and perinatal mortality (e.g., death, ventilation use, sepsis, seizures, injury); secondary neonatal (e.g., shoulder dystocia, hypoglycemia); and neonatal respiratory support/morbidity from chart review. Modified Poisson regression with generalized estimating equations calculated adjusted relative risks (RR) for differences in outcome rates by GDM status and fetus at risk model for outcomes at delivery compared with ongoing pregnancies.
Results:
A higher proportion of GDM pregnancies delivered at each week prior to 39 weeks compared with no diabetes (2.5, 3.9, 7.4, 17.2, 32, and 36.9% for GDM and 1.4, 2.3, 5.0, 11.0, 24.6, and 38.4% for no diabetes, at 34, 35, 36, 37, 38, and 39 weeks, respectively, p < 0.001). Among GDM, compared with ongoing pregnancy, risk of maternal composite was higher for delivery at 37 weeks, 20.5 versus 11.6% (RR: 1.71; 95% confidence interval [CI]: 1.51-1.92) and 38 weeks, 14.9 versus 9.4% (RR: 1.62; 95% CI: 1.42-1.84) driven by hypertensive disorders (18.3% at 37 and 23.5% at 38 vs. 10.1% at 39 weeks); and risk of primary neonatal composite was higher at 37 weeks, 2.3 versus 1.1% (RR: 2.00; 95% CI: 1.33-3.00). Risk of stillbirth was higher at 37 weeks, 0.41 versus 0.11% (RR: 3.62; 95% CI: 1.22-10.75) among GDM, suggesting that it was an indication for earlier delivery.
Conclusion:
For GDM-complicated pregnancies, earlier delivery at 37 and 38 weeks compared with ongoing pregnancy was associated with higher risk of maternal morbidity likely due to having hypertensive disorders and delivery at 37 weeks with higher risk for serious neonatal morbidity.
Key Points:
· Assessed outcomes in GDM pregnancies by delivery week.. · Maternal morbidity risk increased at 37 and 38 weeks.. · Neonatal death was rare and unrelated to GDM status.. · Neonatal morbidity risk increased at 37 weeks..
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

